We are live on ! Find out more
STAA icon

STAAR Surgical

275 hedge funds and large institutions have $2.25B invested in STAAR Surgical in 2022 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 111 increasing their positions, 94 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 94

1.7% less ownership

Funds ownership: 98.59%96.89% (-1.7%)

10% less funds holding

Funds holding: 304275 (-29)

22% less call options, than puts

Call options by funds: $40.1M | Put options by funds: $51.1M

22% less funds holding in top 10

Funds holding in top 10: 97 (-2)

33% less capital invested

Capital invested by funds: $3.34B → $2.25B (-$1.09B)

40% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 63

Holders
275
Holders Change
-29
Holders Change %
-9.54%
% of All Funds
4.42%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.11%
New
38
Increased
111
Reduced
94
Closed
63
Calls
$40.1M
Puts
$51.1M
Net Calls
-$11M
Net Calls Change
-$25.9M
Name Holding Trade Value Shares
Change
Change in
Stake
TCM
276
TimesSquare Capital Management
New York
-$30.3M -429,510 Closed
DCM
277
Driehaus Capital Management
Illinois
-$16.3M -230,734 Closed
AAP
278
Ardsley Advisory Partners
Connecticut
-$12.3M -175,000 Closed
NIP
279
Nicholas Investment Partners
California
-$11.7M -166,316 Closed
Fuller & Thaler Asset Management
280
Fuller & Thaler Asset Management
California
-$8.97M -127,121 Closed
LCG
281
Lisanti Capital Growth
New York
-$4.81M -68,155 Closed
Macquarie Group
282
Macquarie Group
Australia
-$4.62M -64,997 Closed
PCM
283
Portolan Capital Management
Massachusetts
-$4.34M -61,583 Closed
Calamos Advisors
284
Calamos Advisors
Illinois
-$4.17M -59,143 Closed
BM
285
Bridger Management
New York
-$3.28M -46,536 Closed
TI
286
Trexquant Investment
Connecticut
-$3.06M -43,334 Closed
CM
287
Castleark Management
Illinois
-$2.43M -34,440 Closed
MAP
288
Moody Aldrich Partners
Massachusetts
-$1.9M -26,860 Closed
CM
289
Caption Management
Oklahoma
-$1.47M -23,374 Closed
DTL
290
Dynamic Technology Lab
Singapore
-$1.53M -21,660 Closed
PP
291
PDT Partners
New York
-$1.26M -17,906 Closed
Walleye Trading
292
Walleye Trading
New York
-$1.21M -17,108 Closed
ACM
293
AlphaCrest Capital Management
New York
-$1.17M -16,583 Closed
Susquehanna International Group
294
Susquehanna International Group
Pennsylvania
-$951K -15,167 Closed
VF
295
Virtu Financial
New York
-$1.05M -14,860 Closed
Natixis Advisors
296
Natixis Advisors
Massachusetts
-$906K -12,841 Closed
EAM
297
EFG Asset Management
Oregon
-$870K -12,346 Closed
CAM
298
Cresset Asset Management
Illinois
-$753K -10,665 Closed
LFAS
299
Level Four Advisory Services
Texas
-$556K -7,886 Closed
Assenagon Asset Management
300
Assenagon Asset Management
Luxembourg
-$537K -7,617 Closed

STAA Hedge Fund Activity: Q4 2022 in Review

275 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q4 2022, worth a combined $2.25B — down 33% from $3.34B a quarter earlier.

Sellers outnumbered buyers: 63 funds closed out of STAA and 38 opened new positions — a net loss of 25 holders — while 94 trimmed existing stakes and 111 added.

The largest buyer was Millennium Management, adding an estimated $16.4M. The largest seller was Next Century Growth Investors, exiting entirely with an estimated $30.6M sold.

  • 275 institutional investors held STAAR Surgical (STAA) as of Q4 2022, down from 304 in Q3 2022.
  • Funds reported $2.25B of STAAR Surgical stock for Q4 2022, down 33% quarter-over-quarter.
  • 38 funds opened new STAAR Surgical positions in Q4 2022 and 63 closed out, a net change of -25 holders.
  • The largest STAAR Surgical buyer in Q4 2022 was Millennium Management, an estimated $16.4M added.
  • The largest STAAR Surgical seller in Q4 2022 was Next Century Growth Investors, an estimated $30.6M sold.

Based on aggregated 13F filings for Q4 2022.